UNIVERSITY OF UTAH

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1850-02-28

Employees: 10K

Market Cap: -

Website: http://www.utah.edu

Clinical Trials

Processed Amniotic Fluid (pAF) for the Treatment of Chronic Wounds

Phase 1

Terminated

Conditions: Wounds and Injuries

Interventions: Drug: Processed Amniotic Fluid
Other: Standard of Care Wound Treatment Regimen

First Posted Date: 2020-06-18

Last Posted Date: 2024-06-07

Lead Sponsor: University of Utah

Target Recruit Count: 1

Registration Number: NCT04438174

Locations: 🇺🇸
University of Utah Burn Center, Salt Lake City, Utah, United States

Pragmatic Research in Healthcare Settings to Improve Diabetes and Obesity Prevention and Care for Our Program

Not Applicable

Active, not recruiting

Conditions: Diet Habit
Weight Loss
Diabetes

Interventions: Behavioral: Control tracking
Behavioral: MAINTAIN PRIME Lifestyle Coaching

First Posted Date: 2020-06-09

Last Posted Date: 2024-03-19

Lead Sponsor: University of Utah

Target Recruit Count: 269

Registration Number: NCT04420936

Locations: 🇺🇸
University of Utah Health Sciences Center, Salt Lake City, Utah, United States

Immune Cells During Disuse and Recovery

Not Applicable

Recruiting

Conditions: Muscle Disuse

Interventions: Other: Limb immobilization

First Posted Date: 2020-06-04

Last Posted Date: 2024-03-21

Lead Sponsor: University of Utah

Target Recruit Count: 45

Registration Number: NCT04416191

Locations: 🇺🇸
The University of Utah, Salt Lake City, Utah, United States

Cobimetinib in Newly Diagnosed or HMA-treated CMML Patients With RAS Pathway Mutations

Phase 2

Recruiting

Conditions: Chronic Myelomonocytic Leukemia (CMML)

Interventions: Drug: Cobimetinib

First Posted Date: 2020-06-01

Last Posted Date: 2024-02-28

Lead Sponsor: University of Utah

Target Recruit Count: 29

Registration Number: NCT04409639

Locations: 🇺🇸
Oregon Health and Science University, Portland, Oregon, United States
🇺🇸
Huntsman Cancer Institute at University of Utah, Salt Lake City, Utah, United States
🇺🇸
Fred Hutchinson Cancer Research Center, Seattle, Washington, United States

Mediators and Moderators of Pain Neuroscience Education on Disability of Patients With Nonspecific Chronic Low Back Pain

Completed

Conditions: Low Back Pain

Interventions: Behavioral: Pain Neuroscience Education (PNE)

First Posted Date: 2020-05-22

Last Posted Date: 2022-01-25

Lead Sponsor: University of Utah

Target Recruit Count: 249

Registration Number: NCT04399473

Locations: 🇸🇦
King Fiasal Hospital-Physical Therapy Department, Ta'if, Makkah, Saudi Arabia
🇸🇦
King Abdulaziz Hospital-Phyiscal Therapy Department, Ta'if, Makkah, Saudi Arabia
🇸🇦
King Abdulaziz Hospital-Rehabilitation Center, Jeddah, Makkah, Saudi Arabia

and more 3 locations

5-HTP and Creatine for Depression

Phase 2

Completed

Conditions: Major Depressive Disorder

Interventions: Drug: 5-Hydroxytryptophan 100 MG
Drug: Creatine monohydrate
Drug: Placebo
Drug: placebo matched to 5-HTP

First Posted Date: 2020-05-20

Last Posted Date: 2024-07-23

Lead Sponsor: University of Utah

Target Recruit Count: 43

Registration Number: NCT04395183

Locations: 🇺🇸
University of Utah Department of Psychiatry, Salt Lake City, Utah, United States

Precision Guided Tacrolimus Dosing in Pediatric Heart Transplant

Not Applicable

Active, not recruiting

Conditions: Heart Transplant Failure and Rejection

Interventions: Device: Tacrolimus Dosing Support Tool

First Posted Date: 2020-05-08

Last Posted Date: 2025-01-07

Lead Sponsor: University of Utah

Target Recruit Count: 15

Registration Number: NCT04380311

Locations: 🇺🇸
Primary Children's Hospital, Salt Lake City, Utah, United States
🇺🇸
University of Utah, Salt Lake City, Utah, United States

Project MARS: Mobile-Assistance for Regulating Smoking

Not Applicable

Recruiting

Conditions: Current Smoker
Tobacco Smoking

Interventions: Behavioral: Moodsurf
Behavioral: Messages (participants experiencing negative affect & cigarettes are available)
Behavioral: Meditate
Behavioral: Messages (participants not experiencing negative affect & cigarettes are available)
Behavioral: Messages (participants experiencing negative affect & cigarettes are not available)
Behavioral: Joy
Behavioral: Messages (participants not experiencing negative affect & cigarettes are not available)
Behavioral: Imagine
Behavioral: Notice

First Posted Date: 2020-05-06

Last Posted Date: 2022-10-26

Lead Sponsor: University of Utah

Target Recruit Count: 112

Registration Number: NCT04376489

Locations: 🇺🇸
University of Utah, Salt Lake City, Utah, United States

The ExTINGUISH Trial of Inebilizumab in NMDAR Encephalitis

Phase 2

Recruiting

Conditions: Autoimmune Encephalitis
Encephalitis

Interventions: Drug: Placebo
Drug: Inebilizumab

First Posted Date: 2020-05-04

Last Posted Date: 2024-08-27

Lead Sponsor: University of Utah

Target Recruit Count: 116

Registration Number: NCT04372615

Locations: 🇺🇸
University of Iowa, Iowa City, Iowa, United States
🇺🇸
University of Rochester, Rochester, New York, United States
🇳🇱
Erasmus Medical University Center, Rotterdam, Netherlands

and more 25 locations

Prone Positioning in Awake Patients With COVID-19 Requiring Hospitalization

Not Applicable

Terminated

Conditions: COVID-19
Respiratory Failure

Interventions: Behavioral: Intermittent prone positioning instructions
Behavioral: Usual care positioning with no instructions

First Posted Date: 2020-04-29

Last Posted Date: 2020-12-03

Lead Sponsor: University of Utah

Target Recruit Count: 30

Registration Number: NCT04368000

Locations: 🇺🇸
University of Utah Health Sciences Center, Salt Lake City, Utah, United States

Home Terms & Conditions Privacy Policy